Related Experiment Video

Updated: Jul 19, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C

Jinhui Wang1, Tyson H Holmes, Laura Ladron de Guevara

  • 1Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

The Journal of Infectious Diseases
|September 23, 2006
PubMed

Insights

Intrahepatic T cells in chronic hepatitis C patients show memory features but impaired function, indicating their role in liver inflammation and disease pathogenesis. These findings highlight key aspects of the immune response in hepatitis C.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Chronic hepatitis C involves complex immune responses within the liver.
  • Understanding intrahepatic immune cell behavior is crucial for elucidating disease pathogenesis.

Purpose of the Study:

  • To analyze the characteristics of intrahepatic T cells in patients with chronic hepatitis C.
  • To investigate the role of these cells in liver inflammation and immune dysfunction.

Main Methods:

  • Polychromatic flow-cytometry was employed to analyze paired intrahepatic and peripheral lymphocyte samples.
  • Samples were obtained from 37 patients diagnosed with chronic hepatitis C.

Main Results:

  • Intrahepatic T cells showed enrichment of CD45RO+ memory T cells but reduced expression of CD27 and CD28 differentiation markers.
  • The proportion of CD45RO+ and CD28+ T cells correlated with liver inflammation severity.
  • Intrahepatic T cells exhibited defective proliferation, reduced interferon-gamma production, lower perforin levels, and increased Fas/Fas ligand expression compared to peripheral T cells.

Conclusions:

  • Intrahepatic T cells in chronic hepatitis C possess distinct characteristics suggesting their direct involvement in liver inflammation.
  • These cells display a memory phenotype yet exhibit functional defects, contributing to the immunopathogenesis of chronic hepatitis C.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...